Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

CompletedOBSERVATIONAL
Enrollment

588

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Daivobet® Gel

Once daily on areas with plaque psoriasis, treatment duration up to 8 weeks for body skin areas except scalp (scalp up to 4 weeks), treatment may be repeated under medical surveillance.

Trial Locations (1)

91054

University Clinic of Erlangen Nuernberg, Erlangen

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

LEO Pharma GmbH, Neu-Isenburg, Germany

UNKNOWN

lead

LEO Pharma

INDUSTRY